Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Verve Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 92
- −4 vs. Q4 2021
- Shares held
- 46.6M
- +1.49M (+3.3%) vs. Q4 2021
- Total value
- $1.06B
- −$598.7M (−36.0%) vs. Q4 2021
- New holders
- 19
- 39 more added
- Sold out
- 23
- 23 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 3 | $0 |
| Q1 2026 | 3 | $0 |
| Q4 2025 | 4 | $344.0K |
| Q3 2025 | 9 | $1.53M |
| Q2 2025 | 176 | $819.4M |
| Q1 2025 | 191 | $369.3M |
| Q4 2024 | 166 | $443.9M |
| Q3 2024 | 174 | $364.6M |
| Q2 2024 | 167 | $371.8M |
| Q1 2024 | 163 | $1.08B |
| Q4 2023 | 157 | $1.04B |
| Q3 2023 | 134 | $847.0M |
| Q2 2023 | 121 | $1.16B |
| Q1 2023 | 125 | $911.8M |
| Q4 2022 | 123 | $1.21B |
| Q3 2022 | 124 | $2.08B |
| Q2 2022 | 101 | $695.8M |
| Q1 2022 | 92 | $1.06B |
| Q4 2021 | 96 | $1.66B |
| Q3 2021 | 73 | $1.81B |
| Q2 2021 | 69 | $2.25B |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Verve Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rock Creek Group, LP | 0 | $0 | 0.00% | −13,303−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −8,511−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −8,100−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −6,074−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −5,969−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −5,740−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −939−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −330−100.0% | Sold out |
| Eagle Bay Advisors LLC | 0 | $0 | 0.00% | −291−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Elmwood Wealth Management, Inc. | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −26−100.0% | Sold out |